The
spread of antimicrobial resistance (AMR) is a rapidly growing
threat to humankind on both regional and global scales. As countries
worldwide prepare to embrace a One Health approach to AMR management,
which is one that recognizes the interconnectivity between human,
animal, and environmental health, increasing attention is being paid
to identifying and monitoring key contributing factors and critical
control points. Presently, AMR sensing technologies have significantly
progressed phenotypic antimicrobial susceptibility testing (AST) and
genotypic antimicrobial resistance gene (ARG) detection in human healthcare.
For effective AMR management, an evolution of innovative sensing technologies
is needed for tackling the unique challenges of interconnected AMR
across various and different health domains. This review comprehensively
discusses the modern state-of-play for innovative commercial and emerging
AMR sensing technologies, including sequencing, microfluidic, and
miniaturized point-of-need platforms. With a unique view toward the
future of One Health, we also provide our perspectives and outlook
on the constantly changing landscape of AMR sensing technologies beyond
the human health domain.